Peptide GE11–Polyethylene Glycol–Polyethylenimine for targeted gene delivery in laryngeal cancer

Medical Oncology

Volumn 32, Issue 7, 2015, Pages

  Ren, Henglei ^a   Zhou, Liang ^a   Liu, Min ^a   Lu, Weiyue ^a   Gao, Chunli ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

EGFR; Gene delivery; Laryngeal cancer; Nonviral vector; Polyethylenimine

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; GE 11; MACROGOL; NANOCARRIER; PEPTIDE DERIVATIVE; PLASMID DNA; POLYETHYLENEIMINE; UNCLASSIFIED DRUG; GE11 PEPTIDE; MACROGOL DERIVATIVE; NANOPARTICLE; PEPTIDE; POLY(ETHYLENE GLYCOL)-CO-POLY(ETHYLENEIMINE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; LARYNX SQUAMOUS CELL CARCINOMA; MALE; MOLECULAR WEIGHT; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANALOGS AND DERIVATIVES; ANIMAL; GENE THERAPY; GENE TRANSFER; GENE VECTOR; LARYNGEAL NEOPLASMS; NUDE MOUSE; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LARYNGEAL NEOPLASMS; MICE; MICE, NUDE; NANOPARTICLES; PEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; TRANSFECTION;

EID: 84930211233     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0624-9     Document Type: Article

References (21)

1. Kamimura K, Suda T, Zhang G, Liu D. Advances in gene delivery systems. Pharmaceut. Med. 2011;25(5):293–306.
2. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 1996;3(12):1074–80.
3. Sonawane ND, Szoka FC Jr, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem. 2003;278(45):44826–31.
4. Lee M, Kim SW. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res. 2005;22(1):1–10.
5. Bruzzese F, Leone A, Rocco M, Carbone C, Piro G, Caraglia M, Budillon A, et al. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. J Cell Physiol. 2011;226(9):2378–90.
6. Wang JL, Tang GP, Shen J, Hu QL, Xu FJ, Wang QQ, et al. A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma. Biomaterials. 2012;33(18):4597–607.
7. Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, et al. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J. 2005;19(14):1978–85.
8. Milane L, Duan Z, Amiji M. Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer. PLoS ONE. 2011;6(9):24075–86.
9. Ren H, Gao C, Zhou L, Liu M, Xie C, Lu W. EGFR-targeted poly (ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation. Drug Deliv. 2014;. doi:10.3109/10717544.2014.896057.
10. Wang J, Lei Y, Xie C, Lu W, Yan Z, Gao J, et al. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex. Int J Pharm. 2013;458(1):48–56.
11. Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 2009;11(4):671–81.
12. Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol. 2015;11(4):234–42.
13. Nishikawa M, Hashida M. Nonviral approaches satisfying various requirements for effective in vivo gene therapy. Biol Pharm Bull. 2002;25(3):275–83.
14. Lei Y, Wang J, Xie C, Wagner E, Lu W, Li Y, et al. Glutathione-sensitive RGD-poly (ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery. J Gene Med. 2013;15(8–9):291–305.
15. Nguyen J, Xie X, Neu M, Dumitrascu R, Reul R, Sitterberg J, et al. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs. J Gene Med. 2008;10(11):1236–46.
16. Petersen H, Fechner PM, Martin AL, Kunath K, Stolnik S, Roberts CJ, et al. Polyethylenimine-graft-poly (ethyleneglycol) copolymers: influence of copolymer block structure on DNA complex-ation and biological activities as gene delivery system. Bioconjug Chem. 2002;13(4):845–54.
17. Master A, Malamas A, Solanki R, Clausen DM, Eiseman JL, Sen Gupta A. A cell-targeted photodynamic nanomedicine strategy for head and neck cancers. Mol Pharm. 2013;10(5):1988–97.
18. Prabaharan M. Chitosan-based nanoparticles for tumor-targeted drug delivery. Int J Biol Macromol. 2015;72:1313–22.
19. Oh KS, Lee H, Kim JY, Koo EJ, Lee EH, Park JH, et al. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy. J Control Release. 2013;165(1):9–15.
20. Kwon IK, Lee SC, Han B, Park K. Analysis on the current status of targeted drug delivery to tumors. J Control Release. 2012;164(2):108–14.
21. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA. 2008;105(33):11613–8.